INTEGRATED PLATFORM FOR RESEARCH AND DEVELOPMENT OF INNOVATIVE MEDICINES FOR CANCER AND METAPBOLICHE (Q2177181)

From EU Knowledge Graph
Revision as of 09:54, 3 November 2020 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair)
Jump to navigation Jump to search
Project Q2177181 in Italy
Language Label Description Also known as
English
INTEGRATED PLATFORM FOR RESEARCH AND DEVELOPMENT OF INNOVATIVE MEDICINES FOR CANCER AND METAPBOLICHE
Project Q2177181 in Italy

    Statements

    country
    Italy
    0 references
    EU contribution
    466,511.11 Euro
    0 references
    budget
    933,022.21 Euro
    0 references
    co-financing rate
    50.0 percent
    0 references
    start time
    7 November 2016
    0 references
    expected end time
    31 December 2019
    0 references
    beneficiary name (string)
    TES PHARMA S.R.L.
    0 references
    beneficiary
    Q293664
    0 references
    programme
    Umbria - ERDF
    0 references
    coordinate location

    43°7'44.51"N, 12°17'15.79"E
    0 references
    summary
    PIATTAFORMA INTEGRATA PER LA RICERCA E LO SVILUPPO DI FARMACI INNOVATIVI PER MALATTIE ONCOLOGICHE E METABOLICHE - SETUP DI NUOVI SAGGI BIOCHIMICI E CELLULARI AD-HOC (Italian)
    0 references
    INTEGRATED PLATFORM FOR RESEARCH AND DEVELOPMENT OF INNOVATIVE MEDICINES FOR CANCER AND METABOLIC DISEASES — SETUP OF NEW BIOCHEMICAL AND AD-HOC BIOASSAYS (English)
    0 references

    Identifiers

    Italian Unique Project Code
    I38I16000160007
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2177181&oldid=7839939"